UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch

NACompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

July 26, 2017

Primary Completion Date

May 21, 2019

Study Completion Date

September 13, 2023

Conditions
Urothelial CarcinomaBladder CancerUrethral CancerCancer of the Ureter
Interventions
OTHER

Biospecimen Collection

Subjects consent to provide access to archival tumor tissue and whole blood samples for genetic analysis. Subjects also consent to the indefinite use of their specimens and linked clinical information for ongoing or future research related to metastatic urothelial cancer.

Trial Locations (8)

10029

Ichan School of Medicine at Mount Sinai, New York

10065

Memorial Sloan Kettering Cancer Center, New York

19111

Fox Chase Cancer Center, Philadelphia

21287

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

27599

University of North Carolina - Lineberger Comprehensive Cancer Center, Chapel Hill

60637

University of Chicago Medical Center, Chicago

90033

University of Southern Cailfornia, Los Angeles

98109

University of Washignton/Fred Hutchinson Cancer Research Center, Seattle

Sponsors
All Listed Sponsors
collaborator

Bladder Cancer Advocacy Network

OTHER

collaborator

Hoosier Cancer Research Network

OTHER

lead

Matthew Milowsky, MD

OTHER